How to manage seizure as per latest guidelines

Reading File
Finding Sources
Finding Sources
Searching PubMed

seizure management guidelines

Searching the Web

seizure management latest guidelines 2024 2025 AAN epilepsy

Reading File
Reading File
Reading File
Reading Article
Reading File
Finding Sources
Loading Image
Finding Sources
Finding Sources
Searching PubMed

status epilepticus treatment benzodiazepine levetiracetam

Reading File
Reading File
I now have comprehensive information to write a thorough, well-structured response. Let me compile it all.

Seizure Management - Current Guidelines

Overview

Seizure management is divided into three main scenarios:
  1. Active/first unprovoked seizure (acute management and discharge decision)
  2. Status epilepticus (emergency time-sensitive protocol)
  3. Chronic epilepsy (antiseizure drug selection for long-term control)

1. First Unprovoked Seizure

Who to admit vs. discharge?

Current guidelines (Tintinalli's, AAN) do not recommend routine admission or immediate antiseizure drug initiation for a first unprovoked seizure IF the patient has returned to neurologic baseline. Safe discharge is appropriate when:
  • Normal neurologic examination
  • Normal mental status (post-ictal period resolved)
  • Normal non-contrast head CT
  • No acute or chronic medical comorbidities
Admit or consult when the seizure is secondary (i.e., identifiable cause such as CNS infection, metabolic derangement, head trauma, tumor, eclampsia, or toxin).

Risk of recurrence

Risk factors predicting seizure recurrence:
  • Prior brain insult (stroke, trauma)
  • Epileptiform abnormalities on EEG
  • Significant abnormality on brain imaging
  • Nocturnal onset seizure
Recurrence risk after a single unprovoked seizure ranges from 31-71% in the first 12 months. Patients with one or more of the above risk factors should generally be started on treatment. - Harrison's Principles of Internal Medicine, 22E

At discharge

  • Defer EEG and MRI to outpatient setting
  • Driving prohibited until cleared (document per local law)
  • Avoid swimming, heights, and hazardous machinery until cleared
  • Neurologist follow-up arranged

2. Acute Seizure and Status Epilepticus - Emergency Management

The goal is seizure cessation within 30 minutes of presentation. Management proceeds through three phases:
Guidelines for management of active seizures and status epilepticus

Phase 1 - Active Seizure (0-5 minutes): Supportive Care

  • Establish large-bore IV access
  • Airway, breathing, circulation (ABCs)
  • Oxygen, cardiac monitor, pulse oximetry, end-tidal capnography
  • Point-of-care blood glucose - give IV glucose if hypoglycemia suspected (add thiamine if malnourished or alcoholism suspected)
  • Patient protection (padded side rails, lateral positioning)
  • Labs: glucose, BMP, Ca, Mg, lactate, toxicology screen, anticonvulsant levels, pregnancy test if appropriate
  • Normal saline infusion (avoid glucose-containing fluids - incompatible with phenytoin)

Phase 2 - Established Status Epilepticus (5-10 min): Benzodiazepines

First-line: Benzodiazepines - given simultaneously with AED loading
DrugDoseNotes
IV Lorazepam (preferred if IV access)2 mg up to 0.1 mg/kg (max 4 mg), repeat once if neededOnset ~3 min; duration 12-24 h; fewer recurrences than diazepam
IV Diazepam10-20 mg (5-10 mg doses)Onset ~2 min; duration only 15-60 min
IM Midazolam (if no IV access)10 mg (0.2 mg/kg) IMNon-inferior to IV lorazepam in prehospital trials; preferred when IV not available
Plus (simultaneously) - Second-line AED loading:
DrugDoseRate
IV Fosphenytoin (preferred over phenytoin)20 PE/kg150 mg PE/min
IV Phenytoin20 mg/kg in normal salineMax 50 mg/min; monitor BP and ECG
IV Levetiracetam2000-4500 mg (60 mg/kg, max 4500 mg)Equal efficacy to phenytoin/valproate in RCT data
IV Valproic acid40 mg/kg (max 3000 mg)Avoid in pregnancy, liver disease
A 2024 systematic review of 15 CPGs (Vignatelli et al., Epilepsia 2024, PMID 38606469) confirmed broad agreement on benzodiazepine-first, second-line AED approach, though there is less consensus on which specific second-line agent is preferred for established SE.

Phase 3 - Refractory Status Epilepticus (>30 minutes): Anesthetic Agents

If seizures persist despite adequate benzodiazepines + second-line AED:
  • Intubate the patient
  • Neuro-ICU admission + continuous EEG monitoring (mandatory after paralysis)
  • Choose one of:
DrugLoading DoseInfusion
IV Midazolam0.2 mg/kg0.05-2 mg/kg/h
IV Propofol1 mg/kg1-10 mg/kg/h
IV Ketamine-5 mg/kg/h
IV Phenobarbital20 mg/kg50-75 mg/min
Consider adding valproate or phenobarbital if seizures persist after several hours of anesthetic infusion. - Tintinalli's Emergency Medicine and Adams & Victor's Principles of Neurology

Special Situations

  • Do not perform LP during active SE - wait until seizures are controlled
  • Suspect CNS infection: start empiric antibiotics/antivirals immediately without waiting for LP
  • Suspect toxic ingestion: GI decontamination as appropriate
  • Non-convulsive SE (NCSE): suspect in comatose patients; continuous EEG monitoring (NCSE reported in 12-24% of post-cardiac arrest survivors)
  • TBI prophylaxis: 7 days of levetiracetam 500 mg BID (adjusted for renal function) is preferred over phenytoin, which may worsen neurocognitive outcomes

3. Chronic Epilepsy - Antiseizure Drug Selection

Treatment is generally indicated for recurrent seizures or a single seizure with high recurrence risk factors. The principle is monotherapy first, with dose optimization before adding a second agent.

Drug Selection by Seizure Type (Harrison's 22E)

Seizure TypeFirst-LineSecond-Line/Adjunct
Generalized tonic-clonicLamotrigine, Valproic acidLevetiracetam, Topiramate, Zonisamide
Focal (partial)Lamotrigine, Carbamazepine, Oxcarbazepine, Eslicarbazepine, PhenytoinLevetiracetam, Topiramate, Lacosamide
Typical absenceValproic acid, Ethosuximide, LamotrigineTopiramate
Atypical absence / Myoclonic / AtonicValproic acid, Lamotrigine, TopiramateClonazepam, Levetiracetam

Practical prescribing considerations

  • Older drugs (phenytoin, valproate, carbamazepine, phenobarbital, ethosuximide) remain first-line globally due to comparable efficacy and lower cost
  • Newer drugs (lamotrigine, levetiracetam, lacosamide) offer simpler dosing, fewer drug-drug interactions, and better tolerability - increasingly used as first-line monotherapy
  • All antiseizure drugs carry common dose-related side effects: sedation, ataxia, dizziness, diplopia
  • Monitor for idiosyncratic toxicity: rash (especially lamotrigine - risk of SJS), bone marrow suppression, hepatotoxicity
  • Long-term use (especially in elderly) - monitor for osteoporosis
  • Valproate: avoid in women of childbearing age (teratogenic) and liver disease
  • Pregnancy: recent 2025 MONEAD study guidance recommends individualized ASM dose adjustments throughout pregnancy and postpartum

When to consider stopping treatment

  • Seizure-free for 2-5 years (depending on syndrome and risk factors)
  • Normal EEG and imaging
  • Always taper slowly (abrupt cessation risks withdrawal seizures)

Summary Algorithm

Active seizure (any duration)
  → ABCs + IV access + glucose + monitoring
  
≥ 5 min OR established SE
  → Benzodiazepine (IV lorazepam or IM midazolam)
  → Simultaneous 2nd-line AED loading (fosphenytoin / levetiracetam / valproate)
  
Seizures persist > 20-30 min (refractory SE)
  → Intubate + ICU
  → Anesthetic infusion (midazolam / propofol / phenobarbital)
  → Continuous EEG monitoring

Key recent evidence:
  • Vignatelli L et al. Clinical practice guidelines on the management of status epilepticus in adults: A systematic review. Epilepsia. 2024. [PMID 38606469] - confirmed broad agreement on benzodiazepine-first protocol, noted gaps in refractory SE management across 15 international CPGs.
  • MONEAD study (2025) - first evidence-based roadmap for antiseizure medication dose adjustment during pregnancy and postpartum.
Note: Drug doses should be verified against institutional protocols before administration. Consult neurology for new-onset epilepsy, refractory SE, or complex cases.
Sources: Tintinalli's Emergency Medicine (9e), Harrison's Principles of Internal Medicine (22e, 2025), Adams & Victor's Principles of Neurology (12e), Rosen's Emergency Medicine

How to start antibiotics as per latest guidelines! I am an intern doctor now will be working as medical officer for next 2 years please teach me from basics to advance

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web

antimicrobial stewardship antibiotic prescribing guidelines 2024 2025 WHO IDSA

Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

antimicrobial stewardship antibiotic prescribing

Reading File
Reading File
Reading Article
Searching the Web

WHO AWaRe classification antibiotics 2024 Access Watch Reserve prescribing

That's your complete antibiotic prescribing masterclass, structured to take you from "what is an antibiotic?" all the way to advanced stewardship and MDR organism management. Here's a summary of what was covered:
The 12 parts at a glance:
  1. Mechanisms - how antibiotics work and why it matters for dosing (time-dependent vs concentration-dependent)
  2. WHO AWaRe 2025 - the global framework: Access → Watch → Reserve
  3. The 5 Rights - the pre-prescribing mental checklist every single time
  4. Clinical decision process - 5-step method from syndrome identification to starting therapy
  5. Common infections - CAP, UTI, SSTI, Sepsis, Meningitis, Intra-abdominal - with drugs and durations
  6. The 48-72h review - the single most important stewardship habit
  7. Duration - evidence that shorter is almost always better
  8. IV to oral switch - stop keeping patients on IV unnecessarily
  9. Special situations - allergy assessment, renal dosing, pregnancy, surgical prophylaxis
  10. Common mistakes - the pitfalls every junior doctor makes
  11. Local antibiogram - why knowing your hospital's data is non-negotiable
  12. One-page checklist - to use at the bedside every day
The most important single lesson: Cultures before antibiotics, then 48-72h de-escalation. That habit alone separates good prescribers from great ones. Best of luck in your career as a medical officer!

Same for the fluid starting choice of fluid dosage in which case for a junior doctor

Finding Sources
Finding Sources
Searching PubMed

intravenous fluid therapy guidelines crystalloid

Searching the Web

IV fluid therapy guidelines 2024 2025 NICE crystalloid balanced saline sepsis resuscitation

Finding Sources
Finding Sources
Finding Sources
Reading Article
Reading File
Finding Sources
Finding Sources
Searching the Web

ESICM 2025 fluid therapy guideline type balanced crystalloid versus saline recommendations

Finding Sources
Finding Sources
Searching the Web

4D fluid therapy de-resuscitation deresuscitation fluid overload signs assessment 2024 2025

I now have comprehensive data from the 2026 Surviving Sepsis Campaign, 2025 ESICM guidelines, 2025 NICE sepsis guidance, ESICM Part 1 fluid type guideline, and multiple textbooks. Let me compile the full guide.

IV Fluid Therapy - The Complete Junior Doctor's Guide

(Based on 2025-2026 SSC, ESICM, NICE guidelines + major textbooks)

PART 1: THINK OF FLUIDS AS DRUGS

This is the most important mindset shift. Every IV fluid has:
  • An indication (why are you giving it?)
  • A dose (how much?)
  • A route and rate (how fast?)
  • A duration (when do you stop?)
  • Contraindications and side effects (fluids can kill)
Fluid overload is as dangerous as under-resuscitation. Both increase mortality. Your job is to give the right fluid, in the right amount, at the right time - and then stop.

PART 2: THE 4 INDICATIONS FOR IV FLUIDS

Before you hang a bag, classify WHY you are giving fluid. There are only 4 valid reasons:
1. RESUSCITATION   → Restore perfusion in shock (emergency)
2. REPLACEMENT     → Replace ongoing measured losses (drains, NG, stomas, GI losses)
3. MAINTENANCE     → Cover daily physiological needs when patient cannot drink/eat
4. NUTRITION       → Fluid vehicle for feeding (TPN, drug diluents)
Most errors happen when doctors give resuscitation volumes as maintenance or give hypotonic fluids for resuscitation. Always identify which of the 4 you are doing before prescribing.

PART 3: THE FLUID FAMILIES - WHAT'S IN THE BAG

A. Crystalloids (the workhorses)

These are water-based solutions with dissolved electrolytes. They distribute across both intravascular and interstitial spaces. Only 25-30% remains intravascular after 1 hour.

Isotonic Crystalloids (main clinical tools)

FluidNa (mmol/L)Cl (mmol/L)KOtherpHUse for
0.9% Normal Saline (NS)1541540-5.0Hyponatremia, metabolic alkalosis, TBI, hypovolemia
Ringer's Lactate (RL) / Hartmann's1301094Lactate 28 mmol/L, Ca6.5Most resuscitation; preferred over NS
Plasma-Lyte 148140985Acetate, gluconate7.4Closest to plasma; most physiologically balanced
Key message: Balanced crystalloids (RL/Hartmann's, Plasma-Lyte) are preferred over normal saline for most resuscitation (2025 ESICM, 2026 SSC both conditional recommendation).
Why avoid large volumes of 0.9% NS?
  • NS has 154 mmol/L chloride vs plasma's 98-106 mmol/L - far too much chloride
  • Large volumes cause hyperchloremic metabolic acidosis (non-anion gap, easy to miss)
  • Associated with acute kidney injury (AKI) and higher rates of renal replacement therapy
  • Exception: Use NS in TBI (balanced solutions may worsen cerebral edema), hyponatremia correction, and metabolic alkalosis

Hypotonic Crystalloids (maintenance and special use)

FluidContentsUseDo NOT use for
5% Dextrose (D5W)Pure water + glucoseHypernatremia, cellular dehydration, drug diluentResuscitation (only 10% remains IV after 1 hour - essentially just water)
0.45% NaCl (half-NS)Hypotonic salineHypernatremiaResuscitation
0.18% NaCl + 4% Dextrose (Dextrose-saline)Maintenance fluidStandard maintenance when pt NBMDo NOT use as resuscitation fluid
4.5% Dextrose + 0.18% NaClPaediatric maintenance-Resuscitation
Common mistake: Using D5W or dextrose-saline for resuscitation. The glucose is rapidly metabolized, leaving only free water - which distributes into all body compartments and provides almost zero volume expansion. It is dangerous in hyponatremia.

Hypertonic Crystalloids (special use only)

FluidUse
3% NaCl / 7.5% NaClSevere symptomatic hyponatremia, raised ICP (TBI, neurosurgery)
Sodium bicarbonate 8.4%Severe metabolic acidosis, hyperkalaemia, TCA overdose

B. Colloids (use cautiously)

These contain large molecules that stay in the intravascular space longer (close to 100% retention for 1-2 hours). More expensive and more side effects than crystalloids.
ColloidContentsWhen to useWhen NOT to use
Human Albumin 4-5%Human-derived proteinSpontaneous bacterial peritonitis (SBP), hepatorenal syndrome, large-volume paracentesis >5LFirst-line resuscitation in most patients
Human Albumin 20-25%Concentrated albuminDe-resuscitation in fluid overload (mobilizes interstitial fluid back), cirrhosis + hypoalbuminemiaRoutine use
Gelatins (Gelofusine, Haemaccel)Bovine/porcine collagenSome centers use for resuscitationAvoid in renal injury, coagulopathy
HES/Starches (Voluven, Volulyte)Synthetic starchNo valid indication in critically ill patientsSepsis, AKI, critically ill (BANNED in many countries)
DextransSynthetic sugarRarely usedModern practice largely abandoned
Rule for interns: Avoid starches/HES entirely. They increase mortality in sepsis and cause AKI. The 2025 ESICM guidelines recommend crystalloids over albumin for most patients (except cirrhosis where albumin is preferred).

PART 4: THE 4 PHASES OF FLUID THERAPY (ROSE Framework)

This is the modern framework (Surviving Sepsis Campaign 2026, ESICM 2025). Think of every sick patient progressing through these phases:
Phase 1: RESUSCITATION (Salvage)     → Give fluid fast, immediately, 0-6 hours
Phase 2: OPTIMIZATION                → Small targeted challenges, reassess
Phase 3: STABILIZATION               → Maintenance only, no more boluses
Phase 4: EVACUATION (De-resuscitation) → Actively remove excess fluid (diuretics)
The mistake most junior doctors make: Staying in Phase 1 (keep giving boluses) when the patient is actually in Phase 3 or 4. Fluid overload is cumulative and deadly.

PART 5: RESUSCITATION - WHICH FLUID, HOW MUCH, HOW FAST

Step 1: Identify the type of shock

Type of ShockMechanismFluid response?First fluid
Hypovolemic (hemorrhage, dehydration, burns)Loss of intravascular volumeYES - fluid responsiveCrystalloid (RL/Hartmann's); blood if hemorrhagic
Distributive (Sepsis, anaphylaxis, neurogenic)Vasodilation + capillary leakINITIALLY yes, then vasopressorsCrystalloid (RL/Hartmann's)
Cardiogenic (MI, heart failure, arrhythmia)Pump failureNO - fluids worsen itAVOID aggressive fluids; small cautious challenges only; inotropes
Obstructive (PE, tension pneumothorax, tamponade)Mechanical obstructionCautiousTREAT THE CAUSE first; small fluid challenges for PE pending treatment
Critical rule: Do not give large fluid boluses to cardiogenic shock - it will worsen pulmonary edema and kill the patient. Vasopressors and inotropes are the priority.

Step 2: Choose your resuscitation fluid

SituationFirst Choice FluidAvoid
Sepsis / Septic shockBalanced crystalloid (RL/Hartmann's/Plasma-Lyte)0.9% NS in large volumes, colloids, HES
Hemorrhagic shockO-negative blood (immediate), then pRBC + FFP + platelets (1:1:1)Crystalloid only (dilutes clotting factors)
Hypovolemia (non-hemorrhagic: vomiting, diarrhea, DKA)Balanced crystalloid OR NS (depends on electrolytes - see below)Hypotonic fluids, dextrose
DKA0.9% NS initially (first 1-2L), then switch to 0.45% NS or balancedDextrose until BG <250 mg/dL
BurnsHartmann's (Parkland formula)Colloids in first 24h
AnaphylaxisCrystalloid boluses fast + IM adrenaline-
Traumatic Brain Injury0.9% NS OR hypertonic saline (3%)Hypotonic fluids (worsen cerebral edema), RL if hyponatremic
Cirrhosis + hypotensionAlbumin 20-25%Crystalloids in large volume (worsen ascites/edema)

Step 3: How much fluid to give?

Sepsis and septic shock - the current guidance (Surviving Sepsis Campaign 2026 + ESICM 2025):
PhaseVolumeTimeNotes
Initial resuscitationUp to 30 mL/kg IV crystalloidFirst 3 hoursIn obese (BMI >30), calculate on ideal body weight; may give less in cardiogenic/oliguric patients
NICE 2025250 mL boluses, reassess after each; up to 1000 mL then seek senior input10-15 min per bolusSmaller boluses in UK practice
Then: Fluid responsiveness assessment before further boluses-After initial 30 mL/kgDo NOT keep giving blind boluses
Key shift in guidelines (2025-2026): The old "30 mL/kg always" rule is now qualified - use 30 mL/kg as a starting point but reassess frequently and stop if patient is not fluid responsive. Over-resuscitation is now recognized as harmful.

Step 4: Is the patient fluid responsive?

Before giving more fluid beyond the initial bolus, always ask: "Will more fluid increase cardiac output and perfusion?"
Clinical tools to assess fluid responsiveness:
ToolHow to usePositive result (fluid responsive)
Passive Leg Raise (PLR)Raise legs to 45° for 1 minute while head flat; watch HR and BPSBP increase >10 mmHg or CO increase >10% suggests fluid responsive
Fluid challengeGive 250 mL over 10 min; measure responseBP or urine output improvement
Pulse pressure variation (PPV)Requires mechanical ventilation; monitor via arterial linePPV >13% suggests fluid responsive
Stroke volume variation (SVV)Advanced monitoring (PICCO, FloTrac)SVV >10-15% suggests responsive
IVC collapsibility (USS)Point-of-care USS of IVCIVC collapse >50% with respiration suggests fluid responsive
If PLR negative or no response to fluid challenge = patient is not fluid responsive = stop fluids, consider vasopressors.

PART 6: MAINTENANCE FLUIDS - DAILY REQUIREMENTS

When a patient is not able to eat or drink (NBM, post-op, bowel obstruction), they need daily maintenance fluids to replace insensible losses.

Daily fluid and electrolyte requirements (70 kg adult)

RequirementAmount
Water25-35 mL/kg/day (~1500-2500 mL/day)
Sodium1-2 mmol/kg/day (~70-140 mmol/day)
Potassium1 mmol/kg/day (~50-70 mmol/day)
Glucose~50-100 g/day (to prevent starvation ketosis)

Standard maintenance fluid prescription (adult, normal renal function)

Option 1 (UK/Commonwealth): Dextrose-saline 5% + 20 mmol KCl
  • 1L over 8h = 125 mL/h x 3 bags (1L each over 8h = 3L/24h)
  • Each bag contains 0.18% NaCl + 4% dextrose + 20 mmol KCl
Option 2 (when Na+ needed): 0.9% NS + KCl, alternating with dextrose
Adjustments based on electrolytes:
  • Hyponatremia → Use more NS, restrict free water
  • Hypernatremia → Use more free water (D5W or hypotonic saline)
  • Hypokalemia → Add more KCl (max 40 mmol/L in peripheral line, max 10 mmol/h)
  • Hyperkalemia → Remove KCl from fluids entirely
Warning about maintenance in elderly/cardiac patients: The standard 3L/day can cause fluid overload. In heart failure, renal failure, or elderly patients, restrict to 1-1.5L/day unless losses indicate more.

PART 7: REPLACEMENT FLUIDS - MATCH WHAT'S LOST

Replace ongoing losses with a fluid that resembles what's being lost:
LossVolume/dayNaKReplace with
Gastric (vomiting, NG drain)Up to 2-3L60 mmol/L10 mmol/L0.9% NS + KCl
Bile/duodenal (fistula, pancreatic drain)Variable140 mmol/L5 mmol/LHartmann's or NS
Small bowel (fistula, ileostomy)Variable100-140 mmol/L5-15 mmol/LNS or Hartmann's + KCl
DiarrheaVariable40-140 mmol/L10-80 mmol/LHartmann's/NS + KCl
Insensible (fever, sweat)500-1000 mL/dayLowLowD5W or hypotonic
Practical rule: Measure drain/stoma output volumes every 8-12 hours and replace ml-for-ml with appropriate fluid.

PART 8: SPECIAL CLINICAL SCENARIOS

Dehydration (simple, not shocked)

  • Mild (dry mouth, dark urine): Encourage oral fluids if possible
  • Moderate (postural dizziness, tachycardia): 500 mL-1L Hartmann's over 1-2h, reassess
  • Severe (confused, HR >120, SBP <90): Treat as hypovolemic shock - see above

Diabetic Ketoacidosis (DKA)

TimeFluidRateNotes
0-1h0.9% NS1L over 1hAggressive initial resuscitation
1-2h0.9% NS1L over 1h
2-4h0.9% NS or 0.45% NS1L over 2hSwitch if Na+ high
4-8h0.9% NS/0.45% NS with KCl1L over 4hMonitor K+; add KCl when K+ <5 mmol/L
When BG <250 mg/dLSwitch to 5% Dextrose + NS-To continue insulin without further hypoglycemia

Hypernatremia (dehydration / diabetes insipidus)

  • Deficit = 0.6 x weight (kg) x [(Na/140) - 1]
  • Replace slowly with D5W or 0.45% NS (no faster than 0.5-1 mmol/L per hour drop in Na)
  • Correct too fast → cerebral edema → seizures

Hyponatremia

  • Assess volume status first (hypovolemic vs euvolemic vs hypervolemic)
  • Hypovolemic hyponatremia (e.g., vomiting + free water replacement): 0.9% NS
  • SIADH (euvolemic hyponatremia): fluid restrict, treat cause
  • Severe symptomatic (<120 + seizures/coma): 3% hypertonic saline 100 mL IV over 10 min (controlled, senior supervision)
  • Never correct faster than 8-10 mmol/L in 24h → osmotic demyelination syndrome (central pontine myelinolysis)

Post-operative Fluid Management

  • Minimise unnecessary IV fluids post-op ("drip and sip" approach)
  • Most post-op patients can start sips within 4-6h
  • Only use IV maintenance when genuinely unable to take orally
  • Goal-directed fluid therapy (GDFT) in major surgery = reduced complications, faster recovery

PART 9: FLUID OVERLOAD - RECOGNIZE AND ACT

Fluid overload is under-recognized and under-treated. Signs to look for daily:
Clinical signs of fluid overload:
  • Weight gain >1 kg/day (daily weights are the best tool)
  • Peripheral pitting edema (ankles, sacrum)
  • Pulmonary crackles / shortness of breath
  • Rising creatinine (AKI from tissue edema)
  • Abdominal distension / ascites
  • Positive fluid balance (ins > outs over 24h)
  • Worsening oxygenation / new requirement for oxygen
When to de-resuscitate (actively remove fluid):
  • Patient is haemodynamically stable (not shocked)
  • Positive cumulative fluid balance >5-10%
  • Signs of fluid overload as above
  • Use: Furosemide 20-40 mg IV; target negative fluid balance 500 mL-1L/day
The 4 D's of Fluid Therapy (modern stewardship framework): Drug (indication) → Dose → Duration → De-escalation

PART 10: POTASSIUM - THE MOST DANGEROUS ELECTROLYTE

You will spend a lot of time managing potassium. Get this right:
K+ LevelClinical FeaturesAction
<3.0 mmol/L (severe hypoK)Weakness, ileus, arrhythmias, U-waves on ECGIV KCl replacement: 40 mmol/h via central line; 10 mmol/h peripheral; continuous ECG monitoring
3.0-3.5 mmol/L (mild hypoK)Usually asymptomaticOral Sando-K / Slow-K; IV if NBM
5.5-6.0 mmol/L (mild hyperK)ECG: tall tented T-wavesStop K+ inputs (drugs, fluids, diet); furosemide; repeat urgent K+
6.0-6.5 mmol/L (moderate)ECG: widened QRS, flat P-wavesCalcium gluconate 10 mL 10% IV (cardiac protection); insulin-dextrose; salbutamol; sodium bicarbonate
>6.5 mmol/L or any ECG changeEMERGENCY - risk of VFALL of above + consider dialysis; call senior/ICU immediately
Never give IV KCl as a bolus - it causes cardiac arrest. Always dilute and give slowly via pump.

PART 11: MONITORING FLUID THERAPY - WHAT TO CHECK

Hourly/frequent:

  • BP, HR, SpO2, RR
  • Urine output: target ≥0.5 mL/kg/hour (normal = ~30-50 mL/h in adults)
  • Urine output <0.5 mL/kg/h for >2h = oliguria → investigate

Every 4-8 hours (sick patients):

  • Fluid balance (ins vs outs - document meticulously)
  • Lactate (if sepsis/shock): target trend down; <2 mmol/L = adequate perfusion
  • Blood glucose (DKA, TPN, high-dose dextrose)

Daily:

  • Weight (most sensitive measure of fluid status)
  • U&E, creatinine, electrolytes
  • Reassess fluid strategy: still in resuscitation? Time to stop? Time to de-resuscitate?

PART 12: THE MENTAL CHECKLIST - USE IT EVERY TIME

Before prescribing any IV fluid:

✓ WHY am I giving this? (Resuscitation / Replacement / Maintenance / Nutrition)
✓ Is the patient in shock? What TYPE of shock?
✓ Which fluid matches the clinical scenario?
✓ Can they drink instead? (oral always preferred)
✓ What RATE and VOLUME? Document clearly.
✓ Reassessment time? (30 min for bolus; next check for maintenance)
✓ Stop criteria: when will I review and stop this fluid?
✓ Daily: check weight, fluid balance, electrolytes, urine output
✓ Am I adding to fluid overload?

Quick Summary Reference Card

SituationFluid of Choice
Sepsis/Distributive shockBalanced crystalloid (RL/Hartmann's/Plasma-Lyte) boluses
Hemorrhagic shockBlood products (1:1:1 ratio) + crystalloid bridge
Cardiogenic shockMinimal fluid - vasopressors/inotropes
TBI resuscitation0.9% NS or hypertonic saline (NOT hypotonic)
DKA0.9% NS → switch to 0.45% NS → add dextrose when BG <250
Routine maintenanceDextrose-saline + KCl (~1-1.5 mL/kg/h)
Gastric losses (vomiting)0.9% NS + KCl
Large-volume paracentesisAlbumin 8g per litre drained
Hypernatremia correctionD5W or 0.45% NS slowly
Hyponatremia (symptomatic)3% NaCl (senior-supervised, no faster than 1 mmol/L/h)

Key References:
  • Surviving Sepsis Campaign 2026 - Crystalloids first-line; balanced crystalloids over 0.9% NS; up to 30 mL/kg initial resuscitation (SCCM.org)
  • ESICM 2025 Fluid Guideline Part 1 (fluid type) - Balanced crystalloids preferred over isotonic saline for most critically ill patients; albumin for cirrhosis; isotonic saline for TBI
  • ESICM 2025 Fluid Guideline Part 2 (volume) - Up to 30 mL/kg for sepsis with frequent reassessment; restrictive strategy for hemorrhagic shock (PMID 40163133)
  • NICE NG253 (2025) - 250 mL boluses, up to 1000 mL; balanced crystalloid or 0.9% NS if not available
  • Bailey & Love's Short Practice of Surgery, 28e - Fluid type selection, shock resuscitation
  • Miller's Anesthesia, 10e - Fluid responsiveness, hyperchloremic acidosis, dynamic monitoring
Key takeaway for your career as MO: "Drip and sip" - get patients drinking as early as possible, use IV fluids only when genuinely needed, reassess the fluid balance every single day, and actively remove fluid when the patient no longer needs it. Fluid overload has become a recognized cause of morbidity and mortality, just like under-resuscitation.
This is a shared conversation. Sign in to Orris to start your own chat.